Cargando…

The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure

Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Koichi, Amiya, Eisuke, Kakuda, Nobutaka, Kaneko, Hidehiro, Hatano, Masaru, Komuro, Issei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168910/
https://www.ncbi.nlm.nih.gov/pubmed/32012742
http://dx.doi.org/10.3390/diagnostics10020070
_version_ 1783523740401795072
author Narita, Koichi
Amiya, Eisuke
Kakuda, Nobutaka
Kaneko, Hidehiro
Hatano, Masaru
Komuro, Issei
author_facet Narita, Koichi
Amiya, Eisuke
Kakuda, Nobutaka
Kaneko, Hidehiro
Hatano, Masaru
Komuro, Issei
author_sort Narita, Koichi
collection PubMed
description Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failure. Here, we report on the case of a patient with hyperammonemic encephalopathy that was secondary to heart failure, which was effectively treated by lactulose.
format Online
Article
Text
id pubmed-7168910
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71689102020-04-20 The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure Narita, Koichi Amiya, Eisuke Kakuda, Nobutaka Kaneko, Hidehiro Hatano, Masaru Komuro, Issei Diagnostics (Basel) Article Hyperammonemic encephalopathy secondary to heart failure is rare and there had been little reports about effective treatment. Organ hypoperfusion or congestion by heart failure may lead to various organ dysfunctions, and liver and intestinal circulatory impairment might cause ammonia metabolic failure. Here, we report on the case of a patient with hyperammonemic encephalopathy that was secondary to heart failure, which was effectively treated by lactulose. MDPI 2020-01-27 /pmc/articles/PMC7168910/ /pubmed/32012742 http://dx.doi.org/10.3390/diagnostics10020070 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Narita, Koichi
Amiya, Eisuke
Kakuda, Nobutaka
Kaneko, Hidehiro
Hatano, Masaru
Komuro, Issei
The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title_full The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title_fullStr The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title_full_unstemmed The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title_short The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
title_sort efficacy of lactulose for the treatment of hyperammonemic encephalopathy due to severe heart failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168910/
https://www.ncbi.nlm.nih.gov/pubmed/32012742
http://dx.doi.org/10.3390/diagnostics10020070
work_keys_str_mv AT naritakoichi theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT amiyaeisuke theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT kakudanobutaka theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT kanekohidehiro theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT hatanomasaru theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT komuroissei theefficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT naritakoichi efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT amiyaeisuke efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT kakudanobutaka efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT kanekohidehiro efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT hatanomasaru efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure
AT komuroissei efficacyoflactuloseforthetreatmentofhyperammonemicencephalopathyduetosevereheartfailure